TI
EPZM

Trexquant Investment’s Epizyme, Inc EPZM Stock Holding History

Trexquant Investment’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,448
Closed -$203K – 1620
2021
Q2 		$203K Sell
24,448
-18,447
-43% -$156K 0.02% 909
2021
Q1 		$374K Buy
+42,895
New +$444K 0.03% 644
2020
Q4 		– Sell
-48,260
Closed -$576K – 1630
2020
Q3 		$576K Buy
+48,260
New +$646K 0.04% 622
2019
Q4 		– Sell
-31,190
Closed -$322K – 1335
2019
Q3 		$322K Buy
+31,190
New +$393K 0.03% 595
2018
Q3 		– Sell
-24,228
Closed -$328K – 1276
2018
Q2 		$328K Buy
+24,228
New +$377K 0.02% 658
2018
Q1 		– Sell
-17,151
Closed -$215K – 1480
2017
Q4 		$215K Sell
17,151
-11,442
-40% -$166K 0.02% 907
2017
Q3 		$545K Buy
28,593
+16,387
+134% +$250K 0.14% 247
2017
Q2 		$184K Buy
+12,206
New +$185K 0.05% 684
2016
Q3 		– Sell
-37,801
Closed -$387K – 1081
2016
Q2 		$387K Buy
+37,801
New +$421K 0.05% 566
2016
Q1 		– Sell
-35,219
Closed -$564K – 1249
2015
Q4 		$564K Buy
+35,219
New +$522K 0.05% 635
2015
Q3 		– Sell
-11,800
Closed -$283K – 1333
2015
Q2 		$283K Sell
11,800
-45,324
-79% -$872K 0.03% 833
2015
Q1 		$1.07M Buy
57,124
+10,511
+23% +$217K 0.11% 333
2014
Q4 		$879K Buy
+46,613
New +$1.09M 0.16% 214

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Trexquant Investment's EPZM Position: Q3 2021 in Review

Trexquant Investment sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 24,448 shares — an estimated $203K sold.

Trexquant Investment first reported a position in EPZM in Q4 2014 and held it in 13 quarters. The position peaked at $1.07M in Q1 2015. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

  • Trexquant Investment reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 24,448 Epizyme, Inc shares in Q3 2021, an estimated $203K.
  • Trexquant Investment first reported a position in Epizyme, Inc in Q4 2014 and held it in 13 quarters.
  • Trexquant Investment's Epizyme, Inc position peaked at $1.07M in Q1 2015.
  • 116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.